Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/111530
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Current and projected burden of heart failure in the Australian adult population: a substantive but still ill-defined major health issue |
Author: | Chan, Y. Tuttle, C. Ball, J. Teng, T. Ahamed, Y. Carrington, M. Stewart, S. |
Citation: | BMC Health Services Research, 2016; 16(1):501-1-501-10 |
Publisher: | BioMed Central |
Issue Date: | 2016 |
ISSN: | 1472-6963 1472-6963 |
Statement of Responsibility: | Yih-Kai Chan, Camilla Tuttle, Jocasta Ball, Tiew-Hwa Katherine Teng, Yasmin Ahamed, Melinda Jane Carrington and Simon Stewart |
Abstract: | Background: Comprehensive epidemiological data to describe the burden of heart failure (HF) in Australia remain lacking despite its importance as a major health issue. Herewith, we estimate the current and future burden of HF in Australia using best available data. Methods: Australian-specific and the most congruent international epidemiological and health utilisation data were applied to the Australian population (adults aged ≥ 45 years, 8.9 of 22.7 million total population in 2014) on an age and sex-specific basis. We estimated the current incident and prevalent cases of clinically overt/symptomatic HF (predominately those with reduced ejection fraction), hospital activity (diagnosis of HF as a primary or secondary reason for admission) and health care costs in 2014 and future prevalence and burden of HF projected to 2030. Results: We estimated that over 61,000 (6.9 per 1000 person-years) adult Australians aged ≥ 45 years (58 % women) are diagnosed with HF with clinically overt signs and symptoms every year. On a conservative basis, 480,000 (6.3 %, 95 % CI 2.6 to 10.0 %) Australians (66 % men) are now affected by the syndrome with > 150,000 hospitalisations in excess of 1 million days in hospital per annum. The annual cost of managing HF in the community is approximately $900 million and nearly $2.7 billion ($1.5 versus $1.2 billion, men versus women) when considering the additional cost of in-patient care. We predict that the prevalence and future burden of HF will continue to increase over the next 10-15 years to nearly 750,000 people with an estimated annual health care cost of $3.8 billion. Conclusions: Australia is not immune to the growing magnitude and implications of a sustained epidemic of HF in an ageing population. However, its public health and economic burden will remain ill-defined until more definitive Australian-specific data are generated. |
Keywords: | Heart failure; prevalence; incidence; economic burden |
Rights: | © 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
DOI: | 10.1186/s12913-016-1748-0 |
Grant ID: | http://purl.org/au-research/grants/nhmrc/1041796 http://purl.org/au-research/grants/nhmrc/1112829 |
Published version: | http://dx.doi.org/10.1186/s12913-016-1748-0 |
Appears in Collections: | Aurora harvest 8 Medicine publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hdl_111530.pdf | Published version | 1.12 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.